Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor

被引:8
作者
Espy, Nicole [1 ]
Pacheco, Beatriz [2 ,3 ]
Sodroski, Joseph [1 ,2 ,3 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[2] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA
基金
美国国家卫生研究院;
关键词
CD4; Trigger; Receptor; Virus entry; Membrane fusion; IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN INCORPORATION; SHORT-TERM MONOTHERAPY; CRYO-EM STRUCTURE; DRUG-BOUND CCR5; NEUTRALIZATION SENSITIVITY; CD4; INDEPENDENCE; MARAVIROC-RESISTANT; EXTRACELLULAR LOOP; FUSION INHIBITORS;
D O I
10.1016/j.virol.2017.04.033
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
binding of the human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimer ((gp120/gp41)(3)) to the receptors CD4 and CCR5 triggers virus entry into host cells. To identify Env regions that respond to CCR5 binding, HIV-1 was serially passaged on a CD4-positive canine cell line expressing progressively lower levels of CCR5. HIV-1 replication was observed in cells expressing similar to 1300 CCR5 molecules/cell. Env changes that conferred this low-CCR5 replication phenotype were located outside of the known CCR5-binding region of the gp120 Env subunit and did not apparently increase CCR5 binding affinity. The adaptation-associated changes, located in the gp120 alpha 1 helix and in the gp41 HR1 heptad repeat and membrane-proximal external region (MPER), enhanced HIV-1 replication in cells at all levels of CCR5 expression. The adapted Envs exhibited a greater propensity to undergo conformational changes, as evidenced by increased exposure of conserved regions near the CD4- and CCR5-binding sites.
引用
收藏
页码:90 / 107
页数:18
相关论文
共 110 条
[1]   Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7 [J].
Aarons, EJ ;
Beddows, S ;
Willingham, T ;
Wu, LJ ;
Koup, RA .
VIROLOGY, 2001, 287 (02) :382-390
[2]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[3]   Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer [J].
Alsahafi, Nirmin ;
Debbeche, Olfa ;
Sodroski, Joseph ;
Finzi, Andres .
PLOS ONE, 2015, 10 (04)
[4]   Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41 [J].
Anastasopoulou, Cleo G. ;
Ketas, Thomas J. ;
Depetris, Rafael S. ;
Thomas, Antonia M. ;
Klasse, Per Johan ;
Moore, John P. .
VIROLOGY, 2011, 413 (01) :47-59
[5]   Effects of sequence changes in the HIV-1 gp41 fusion peptide on CCR5 inhibitor resistance [J].
Anastassopoulou, Cleo G. ;
Ketas, Thomas J. ;
Sanders, Rogier W. ;
Klasse, Per Johan ;
Moore, John P. .
VIROLOGY, 2012, 428 (02) :86-97
[6]   Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41 [J].
Anastassopoulou, Cleo G. ;
Ketas, Thomas J. ;
Klasse, Per Johan ;
Moore, John P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (13) :5318-5323
[7]  
[Anonymous], BLOOD, DOI [10.1182/blood-2010-09-309591, DOI 10.1182/BLOOD-2010-09-309591]
[8]   V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc [J].
Berro, Reem ;
Klasse, Per Johan ;
Moore, John P. ;
Sanders, Rogier W. .
VIROLOGY, 2012, 427 (02) :158-165
[9]   Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors [J].
Berro, Reem ;
Klasse, Per Johan ;
Lascano, Danny ;
Flegler, Ayanna ;
Nagashima, Kirsten A. ;
Sanders, Rogier W. ;
Sakmar, Thomas P. ;
Hope, Thomas J. ;
Moore, John P. .
JOURNAL OF VIROLOGY, 2011, 85 (16) :8227-8240
[10]   Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120 [J].
Binley, JM ;
Wyatt, R ;
Desjardins, E ;
Kwong, PD ;
Hendrickson, W ;
Moore, JP ;
Sodroski, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) :191-198